Hermann Kollmann

Title: Hermann Kollmann: Innovator in Pharmaceutical Chemistry

Introduction

Hermann Kollmann is a notable inventor based in Linz, Austria. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 4 patents, Kollmann's work has advanced the development of new therapeutic compounds.

Latest Patents

Kollmann's latest patents include groundbreaking compounds such as Siderophore cephalosporin conjugates and 12-epi pleuromutilins. The Siderophore cephalosporin conjugates patent describes a complex compound with specific structural features that enhance its pharmaceutical applications. The 12-epi pleuromutilins patent outlines a compound characterized by unique substituents on the mutilin ring, which are designed for use as pharmaceuticals.

Career Highlights

Throughout his career, Kollmann has worked with prominent companies in the pharmaceutical industry, including Nycomed Imaging and Nabriva Therapeutics. His experience in these organizations has allowed him to collaborate on various innovative projects that have contributed to advancements in drug development.

Collaborations

Kollmann has collaborated with notable colleagues such as Jessie Sandosham and Johann Hiebl. These partnerships have fostered a creative environment for innovation and have led to the successful development of new pharmaceutical solutions.

Conclusion

Hermann Kollmann's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant innovator in the field. His work continues to influence the development of new therapeutic compounds that can improve patient outcomes.